Savara: Simple Platform Targeting A Few Rare Diseases
(WorldNews Health)

Savara Pharmaceuticals (SVRA) has developed a nanoparticles-based technology called NanoCluster that emulates naturally occurring aerosols like soot and spores to deliver standard drugs into deep lung. Drugs with low water solubility can greatly enhance their dissolution when used in aerosol format. Current aerosol-based drug molecules may be too large or too small, limiting their spread to the deep lung. According to a report: ... current dry powder drugs have several disadvantages. Their manufacturing process requires large spray-drying facilities. The pulverized drugs are blended with excipients, which are materials added to improve the flow and handling of dry powders. The drug must...